Daria Lemann-Blumenthal is a visionary leader in the medical device industry, currently serving as the Chief Executive Officer of BELKIN Vision. With a robust background in business planning and international business, Daria is at the forefront of developing innovative solutions to combat glaucoma, a condition...
Daria Lemann-Blumenthal is a visionary leader in the medical device industry, currently serving as the Chief Executive Officer of BELKIN Vision. With a robust background in business planning and international business, Daria is at the forefront of developing innovative solutions to combat glaucoma, a condition that affects approximately 70 million people globally and is the leading cause of irreversible blindness. Under her leadership, BELKIN Laser is pioneering an intuitive automated one-second glaucoma laser treatment that promises to revolutionize accessibility to glaucoma care.
Daria's expertise in product management and clinical research has been instrumental in guiding BELKIN Laser through its clinical stage, emphasizing the importance of a simple, painless, and non-invasive procedure. The treatment leverages advanced image acquisition algorithms, making it not only effective but also user-friendly for both patients and healthcare providers. Her strategic vision and entrepreneurial spirit have driven the company’s efforts in new business development and fundraising, ensuring that BELKIN Vision remains at the cutting edge of medical technology.
With a strong foundation in R&D and a commitment to improving patient outcomes, Daria is dedicated to bridging the gap between innovative medical solutions and the healthcare market. Her leadership is characterized by a focus on collaboration and partnerships, essential for navigating the complexities of mergers and acquisitions in the medical device sector. As BELKIN Vision continues to expand its reach, Daria Lemann-Blumenthal stands out as a key player in transforming glaucoma treatment and enhancing the quality of life for millions worldwide.
